Evidence map›Paper›PMID 26026596›Full record

ArticleEuropean journal of endocrinology2015

Response to inquiry by Gaylinn et al. on 'Administration of UAG improves glycemic control in obese subjects with diabetes'.

Behiye Özcan, Sebastian J C M M Neggers, Anne Reifel Miller, Hsiu-Chiung Yang, Virginia Lucaites, Thierry Abribat, Soraya Allas, Martin Huisman, Jenny A Visser, Axel P N Themmen and 3 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in European journal of endocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Beyond Hunger: The Structure, Signaling, and Systemic Roles of Ghrelin.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Behiye ÖzcanDepartment of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
Sebastian J C M M NeggersDepartment of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
Anne Reifel MillerDepartment of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
Hsiu-Chiung YangDepartment of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France yang_hsiu-chiung@Lilly.com.
Virginia LucaitesDepartment of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
Thierry AbribatDepartment of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
Soraya AllasDepartment of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
Martin HuismanDepartment of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
Jenny A VisserDepartment of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
Axel P N ThemmenDepartment of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
Eric J G SijbrandsDepartment of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
Patric J D DelhantyDepartment of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
Aart Jan van der LelyDepartment of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blood GlucoseFemaleGhrelinHumansMaleObesityBlood GlucoseGhrelin

Identifiers

PMID26026596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.